Year: 2025
Type: editorial
Abstract: High blood pressure (BP) is the leading risk factor for global morbidity and mortality.1,2 Despite decades of intense public health efforts and the widescale availability of inexpensive medications, only about 1 in 5 adults with hypertension worldwide has their BP controlled (<140/90 mm Hg). Nearly half remain unaware of their condition. The health statistics are better in the United States; however, only marginally so when a BP goal of <130/80 mm Hg is considered (e.g., 25% control rate).3 Particularly, disconcerting is that 36% of adults with hypertension in the US remain unaware of their high BP. While this failure impacts the population relatively equally (e.g., race, sex), it is especially problematic among younger adults. Moreover, for a number of reasons (e.g., costs), a rising percentage of people (30%-38%) report deliberately avoiding contact with the medical system (30%-38%)4 and, as such, the true prevalence of undiagnosed hypertension in the US may be even worse.
Source: American Journal of Hypertension
DOI: 10.1093/ajh/hpaf009
Institutions: Wayne State University, University of Michigan, Michigan Medicine
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Linkage, Empowerment, and Access to Prevent Hypertension (LEAP-HTN), G6429544020, G8212714351, Aldosterone and the menopausal transition's increase in blood pressure and cardiovascular risk, ACHIEVE GreatER: Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region
OpenAlex ID: W4406352540